Abstract
Aim Iron deficiency anemia (IDA) among preterm infants is a global public health problem due to its effects on development, immunity and general growth that may be irreversible. Despite the high burden of preterm births in Tanzania the prevalence and factors associated with IDA among preterm infants remains relatively understudied and this constituted of the aim of this study.
Methods A cross-sectional analytical study design was conducted among 190 preterm infants who attended pediatric clinic in Dodoma City from December 2022 to May 2023. Socio-demographic, clinical information, and laboratory markers of hemoglobin and iron status were obtained. Logistic regression analysis was applied to determine factors associated with the outcome (Iron Deficiency Anaemia).
Results A total of 190 preterm infants were enrolled in the study and the mean age was 4.01 months (SD ±0.99 month. The prevalence of IDA among preterm infants was 11.58%. Factors associated with IDA were very low birth weight (AOR 6.906, CI: 1.4774-32.359, p value < 0.0142), preterm infant not supplemented with Iron (AOR 6.282, CI:1.045-37.763, p value< 0.0446, multiple pregnancies (AOR 6.848, CI:1.692-27.708, p value <0.0006) and severe anaemia during pregnancy (AOR 11.998, CI:5.068-40.197, p value< 0.0001).
Conclusion Iron deficiency anemia was found to be 11.58% which fall under public health problem under WHO classification. To reduce IDA among preterm infants, there has to be an emphasis on iron supplementation to all preterm infants, and those with very low birth weight, born from mother who had multiple pregnancy and severe anaemia during pregnancy need close follow up and improved postnatal
Keynotes
This study enrolled 190 preterm infants attending pediatric clinic in Dodoma city to determine factors associated with iron deficiency anaemia (IDA)
Globally IDA in preterm infants range between 25 to 80, which complicates their prematurity by causing poor growth, poor functioning of multiple organ systems, poor neurological development and contributes to death and disability
Iron supplementation to all preterm infants is highly recommended
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Enrolment was done only after parents/guardians had signed a written informed consent at admission in the neonatal ward. Ethical approval to conduct the study was granted by the University of Dodoma research and ethical review board with ethical clearance reference number MA.84/261/59/154.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
